ProPhotonix Limited ProPhotonix Awarded a two-year Supply Agreement (4212M)
May 07 2015 - 2:01AM
UK Regulatory
TIDMPPIX TIDMPPIR
RNS Number : 4212M
ProPhotonix Limited
07 May 2015
May 7, 2015
ProPhotonix Limited
("ProPhotonix" or "the Company")
ProPhotonix Awarded a two year Supply Agreement
from a Pharmaceutical Customer
ProPhotonix Limited, (London Stock Exchange - AIM: PPIX and
PPIR; OTC: STKR), a designer and manufacturer of LED illumination
systems and laser diode modules with operations in Ireland and the
United Kingdom,today announces the award of a two year supply
agreement, for custom LED illumination devices, from a leading
global manufacturer of drug delivery products. Deliveries are
expected to begin in the second half 2015 and continue through May
2017.
The LED illuminator, consisting of 100's of LEDs with an input
power of >1 kilowatt, is designed with a dynamic operating
current range from 1 milliamp ("mA") up to 10,000mA with a 1mA
resolution precision. Heat dissipation from the LEDs is
approximately 600 watts requiring a reliable water-cooled heat
management system. The illuminator operates in either continuous
mode or strobe mode (200Hz, 10% duty cycle). Complex software
manages multichannel control and monitoring, thermal management,
and other such operating protection features.
The supply agreement does not stipulate or require that the
customer makes any purchases. The expected revenue to the Company,
during the term of the agreement, could be EUR975,000 if fulfilled
at the expected quantities.
Commenting on the Agreement, David McGuinness, Sales Director -
EMEA, of ProPhotonix Limited said, "This is a second generation
product for the customer and the result of several years of
development by our LED engineering team. The successful product
began with customer collaboration, a custom design, prototype
devices, and ultimately production ready illuminators. The
application of this ProPhotonix illuminator is to ensure the
efficacy of the end product in a production environment running at
speeds of up to 100 units per second. We are delighted to provide
unique custom solutions for our customers, enabling competitive
advantage in their respective markets."
Tim Losik, President and CEO of ProPhotonix stated, "This
project illustrates an ever increasing trend ProPhotonix is seeing,
where it is an absolute necessity to have in-house engineering
design expertise in optics, electronics, mechanics, materials,
software and manufacturing and for compete integration between
these functional areas to meet customers' specification and target
price. With over 15 years experience in Custom LED and Laser Module
design, ProPhotonix delivers such solutions across the wide range
of industries we supply including the dental, medical and
pharmaceutical industries."
Enquiries:
ProPhotonix Limited Tel: +1 603 893 8778
Tim Losik, President and CEO ir@prophotonix.com
N+1 Singer Tel: +44 (0) 207 496
Ben Wright, Richard Salmond 3000
Nominated Adviser and Broker
About ProPhotonix
ProPhotonix Limited, headquartered in Salem, New Hampshire, is
an independent designer and manufacturer of diode-based laser
modules and LED systems for industry leading OEMs and medical
equipment companies. In addition, the Company distributes premium
diodes for Ushio (formerly Opnext), Osram, QSI, Panasonic, and
Sony. The Company serves a wide range of markets including the
machine vision, industrial inspection, security, and medical
markets. ProPhotonix has offices and subsidiaries in the U.S.,
Ireland, U.K., and Europe. For more information about ProPhotonix
and its innovative products, visit the Company's web site at
www.prophotonix.com
Cautionary Statement
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934. All statements
other than statements of historical fact, including without
limitation, those with respect to ProPhotonix's goals, plans and
strategies set forth herein are forward-looking statements. The
following important factors and uncertainties, among others, could
cause actual results to differ materially from those described in
these forward-looking statements: uncertainty that cash balances
may not be sufficient to allow ProPhotonix to meet all of its
business goals; uncertainty that ProPhotonix's new products will
gain market acceptance; the risk that delays and unanticipated
expenses in developing new products could delay the commercial
release of those products and affect revenue estimates; the risk
that one of our competitors could develop and bring to market a
technology that is superior to those products that we are currently
developing; and ProPhotonix's ability to capitalize on its
significant research and development efforts by successfully
marketing those products that the Company develops. Forward-looking
statements represent management's current expectations and are
inherently uncertain. All Company, brand, and product names are
trademarks or registered trademarks of their respective holders.
ProPhotonix undertakes no duty to update any of these
forward-looking statements.
#######
This information is provided by RNS
The company news service from the London Stock Exchange
END
AGRBCGDUISGBGUL
Prophotonix S (LSE:PPIR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Prophotonix S (LSE:PPIR)
Historical Stock Chart
From Jul 2023 to Jul 2024